Anticuerpos que unen CTLA-4 y sus usos
Se describen anticuerpos monoclonales aislados, que comprenden un dominio de unión a CD152, en donde los anticuerpos se unen específicamente a CD152 humano. También se proporcionan métodos para producir y usar los anticuerpos para tratar enfermedades que incluyen cánceres y enfermedades autoinmunita...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DRABEK, Dubravka SHEN, Yuqiang HE, Yun VAN HAPEREN, Marinus (Rien) GAN, Xin RONG, Yiping ZHAO, Jiuqiao JANSSENS, Rick GROSVELD, Frank |
| description | Se describen anticuerpos monoclonales aislados, que comprenden un dominio de unión a CD152, en donde los anticuerpos se unen específicamente a CD152 humano. También se proporcionan métodos para producir y usar los anticuerpos para tratar enfermedades que incluyen cánceres y enfermedades autoinmunitarias. (Traducción automática con Google Translate, sin valor legal)
Disclosed are isolated monoclonal antibodies, comprising a CD152-binding domain, wherein the antibodies bind specifically to human CD152. Methods of making and using the antibodies to treat diseases including cancers and autoimmune diseases are also provided. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2965187TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2965187TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2965187TT33</originalsourceid><addsrcrecordid>eNrjZFBzzCvJTC5NLSrIL1YoLE1VKM1LzVNwDvFx1DVRqFQoLi1WKC3OL-ZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGuwUaWZqaGFuYhIcbGxKgBABSrJww</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anticuerpos que unen CTLA-4 y sus usos</title><source>esp@cenet</source><creator>DRABEK, Dubravka ; SHEN, Yuqiang ; HE, Yun ; VAN HAPEREN, Marinus (Rien) ; GAN, Xin ; RONG, Yiping ; ZHAO, Jiuqiao ; JANSSENS, Rick ; GROSVELD, Frank</creator><creatorcontrib>DRABEK, Dubravka ; SHEN, Yuqiang ; HE, Yun ; VAN HAPEREN, Marinus (Rien) ; GAN, Xin ; RONG, Yiping ; ZHAO, Jiuqiao ; JANSSENS, Rick ; GROSVELD, Frank</creatorcontrib><description>Se describen anticuerpos monoclonales aislados, que comprenden un dominio de unión a CD152, en donde los anticuerpos se unen específicamente a CD152 humano. También se proporcionan métodos para producir y usar los anticuerpos para tratar enfermedades que incluyen cánceres y enfermedades autoinmunitarias. (Traducción automática con Google Translate, sin valor legal)
Disclosed are isolated monoclonal antibodies, comprising a CD152-binding domain, wherein the antibodies bind specifically to human CD152. Methods of making and using the antibodies to treat diseases including cancers and autoimmune diseases are also provided.</description><language>spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240411&DB=EPODOC&CC=ES&NR=2965187T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240411&DB=EPODOC&CC=ES&NR=2965187T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DRABEK, Dubravka</creatorcontrib><creatorcontrib>SHEN, Yuqiang</creatorcontrib><creatorcontrib>HE, Yun</creatorcontrib><creatorcontrib>VAN HAPEREN, Marinus (Rien)</creatorcontrib><creatorcontrib>GAN, Xin</creatorcontrib><creatorcontrib>RONG, Yiping</creatorcontrib><creatorcontrib>ZHAO, Jiuqiao</creatorcontrib><creatorcontrib>JANSSENS, Rick</creatorcontrib><creatorcontrib>GROSVELD, Frank</creatorcontrib><title>Anticuerpos que unen CTLA-4 y sus usos</title><description>Se describen anticuerpos monoclonales aislados, que comprenden un dominio de unión a CD152, en donde los anticuerpos se unen específicamente a CD152 humano. También se proporcionan métodos para producir y usar los anticuerpos para tratar enfermedades que incluyen cánceres y enfermedades autoinmunitarias. (Traducción automática con Google Translate, sin valor legal)
Disclosed are isolated monoclonal antibodies, comprising a CD152-binding domain, wherein the antibodies bind specifically to human CD152. Methods of making and using the antibodies to treat diseases including cancers and autoimmune diseases are also provided.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBzzCvJTC5NLSrIL1YoLE1VKM1LzVNwDvFx1DVRqFQoLi1WKC3OL-ZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGuwUaWZqaGFuYhIcbGxKgBABSrJww</recordid><startdate>20240411</startdate><enddate>20240411</enddate><creator>DRABEK, Dubravka</creator><creator>SHEN, Yuqiang</creator><creator>HE, Yun</creator><creator>VAN HAPEREN, Marinus (Rien)</creator><creator>GAN, Xin</creator><creator>RONG, Yiping</creator><creator>ZHAO, Jiuqiao</creator><creator>JANSSENS, Rick</creator><creator>GROSVELD, Frank</creator><scope>EVB</scope></search><sort><creationdate>20240411</creationdate><title>Anticuerpos que unen CTLA-4 y sus usos</title><author>DRABEK, Dubravka ; SHEN, Yuqiang ; HE, Yun ; VAN HAPEREN, Marinus (Rien) ; GAN, Xin ; RONG, Yiping ; ZHAO, Jiuqiao ; JANSSENS, Rick ; GROSVELD, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2965187TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DRABEK, Dubravka</creatorcontrib><creatorcontrib>SHEN, Yuqiang</creatorcontrib><creatorcontrib>HE, Yun</creatorcontrib><creatorcontrib>VAN HAPEREN, Marinus (Rien)</creatorcontrib><creatorcontrib>GAN, Xin</creatorcontrib><creatorcontrib>RONG, Yiping</creatorcontrib><creatorcontrib>ZHAO, Jiuqiao</creatorcontrib><creatorcontrib>JANSSENS, Rick</creatorcontrib><creatorcontrib>GROSVELD, Frank</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DRABEK, Dubravka</au><au>SHEN, Yuqiang</au><au>HE, Yun</au><au>VAN HAPEREN, Marinus (Rien)</au><au>GAN, Xin</au><au>RONG, Yiping</au><au>ZHAO, Jiuqiao</au><au>JANSSENS, Rick</au><au>GROSVELD, Frank</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anticuerpos que unen CTLA-4 y sus usos</title><date>2024-04-11</date><risdate>2024</risdate><abstract>Se describen anticuerpos monoclonales aislados, que comprenden un dominio de unión a CD152, en donde los anticuerpos se unen específicamente a CD152 humano. También se proporcionan métodos para producir y usar los anticuerpos para tratar enfermedades que incluyen cánceres y enfermedades autoinmunitarias. (Traducción automática con Google Translate, sin valor legal)
Disclosed are isolated monoclonal antibodies, comprising a CD152-binding domain, wherein the antibodies bind specifically to human CD152. Methods of making and using the antibodies to treat diseases including cancers and autoimmune diseases are also provided.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2965187TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Anticuerpos que unen CTLA-4 y sus usos |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T14%3A43%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DRABEK,%20Dubravka&rft.date=2024-04-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2965187TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |